Rakesh K. Puni1, M J. Henderson1,
Lowri Morus1, C Green1, Faiza Admiraa-Behloul2,
S Roy-Choudhury1
1Heart of England NHS Foundation Trust,
Birmingham, United Kingdom; 2MR-BU, Toshiba Meidcal Systems
Europe, Zoetermeer, Netherlands
With
Nephrogenic systemic fibrosis (NSF) receiving considerable attention,
non-contrast enhanced (NCE) MRA appears to be a feasible alternative to
contrast enhanced (CE) MRA. Fresh Blood Imaging (FBI) is a NCE technique that
was introduced in late 90s by M Miyazaki and co-workers, and has gained
popularity only very recently after
the NSF-Gadolinium link has been reported in patients with impaired renal
function. The purpose of this pilot study was to compare FBI technique to
CE-MRA using DSA as the reference standard.